Identification and characterization of triamcinolone acetonide, a microglial-activation inhibitor

ISSN： 0892-3973

Source： Immunopharmacology and Immunotoxicology, Vol.34, Iss.6, 2012-12, pp. : 912-918

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics of triamcinolone acetonide for the treatment of macular edema

By Yilmaz Taygan Cordero-Coma Miguel Federici Thomas J

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 10, 2011-10 ,pp. : 1327-1335

Informa Healthcare

Access to resources Recommend Favorite

Enhanced permeation of triamcinolone acetonide through the buccal mucosa

By Shin S.-C. Kim J.-Y.

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Iss. 2, 2000-09 ,pp. : 217-220

Elsevier

Access to resources Recommend Favorite

Drug safety evaluation of intravitreal triamcinolone acetonide

By Veritti Daniele Di Giulio Andrea Sarao Valentina Lanzetta Paolo

Expert Opinion on Drug Safety, Vol. 11, Iss. 2, 2012-03 ,pp. : 331-340

Informa Healthcare

Access to resources Recommend Favorite

Triamcinolone acetonide: Failure to thrive and Cushing's syndrome in an infant: case report

Reactions Weekly, Vol. 1, Iss. 1199, 2008-01 ,pp. : 44-45

Adis International

Access to resources Recommend Favorite

A Risk-Benefit Assessment of Intranasal Triamcinolone Acetonide in Allergic Rhinitis

By Gawchik S.M. Saccar C.L.

Drug Safety, Vol. 23, Iss. 4, 2000-10 ,pp. : 309-322

Adis International

Access to resources Recommend Favorite